Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹1,036 Cr₹928 Cr₹590 Cr₹611 Cr₹1,695 Cr

What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,036 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹1,036 Cr
Mar2025₹928 Cr
Mar2024₹590 Cr
Mar2023₹611 Cr
Mar2022₹1,695 Cr

How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹1,036 Cr
11.69
Mar2025 ₹928 Cr
57.23
Mar2024 ₹590 Cr
-3.39
Mar2023 ₹611 Cr
-63.97
Mar2022 ₹1,695 Cr -

Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹113,589.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses